T3 Companies’s Yarrow Bioscience YARW Stock Holding History

T3 Companies’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$615K	Hold	18,900	–	–	0.66%	28
2026 Q1	$565K	Hold	18,900	–	–	0.74%	27
2025 Q4	$548K	Buy	+18,900	New	+$379K	0.68%	31

Other funds holding YARW

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $136M AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

T3 Companies's YARW Position: Q2 2026 in Review

T3 Companies held its Yarrow Bioscience (YARW) position steady in Q2 2026 at 18,900 shares worth $615K. The position accounts for 0.66% of the portfolio, ranked #28.

T3 Companies first reported a position in YARW in Q4 2025 and has held it in 3 quarters since. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

T3 Companies held 18,900 shares of Yarrow Bioscience worth $615K as of Q2 2026.
T3 Companies left its Yarrow Bioscience share count unchanged in Q2 2026.
Yarrow Bioscience made up 0.66% of T3 Companies's portfolio in Q2 2026, its #28 holding.
T3 Companies first reported a position in Yarrow Bioscience in Q4 2025 and has held it in 3 quarters since.
40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on T3 Companies's 13F filing for Q2 2026, filed 27 Jul 2026.